89bio Statistics
Share Statistics
89bio has 145.98M
shares outstanding. The number of shares has increased by 48.38%
in one year.
| Shares Outstanding | 145.98M |
| Shares Change (YoY) | 48.38% |
| Shares Change (QoQ) | 24.16% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 752 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 17.03M, so 11.67% of the outstanding
shares have been sold short.
| Short Interest | 17.03M |
| Short % of Shares Out | 11.67% |
| Short % of Float | 16.24% |
| Short Ratio (days to cover) | 7.38 |
Valuation Ratios
The PE ratio is -2.23 and the forward
PE ratio is -3.69.
89bio's PEG ratio is
-0.03.
| PE Ratio | -2.23 |
| Forward PE | -3.69 |
| PS Ratio | 0 |
| Forward PS | 1.5 |
| PB Ratio | 2.04 |
| P/FCF Ratio | -2.23 |
| PEG Ratio | -0.03 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for 89bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.19,
with a Debt / Equity ratio of 0.09.
| Current Ratio | 13.19 |
| Quick Ratio | 13.19 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | -0.1 |
| Debt / FCF | -0.1 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-3,947,086.02 |
| Employee Count | 93 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 692K |
| Effective Tax Rate | -0.19% |
Stock Price Statistics
The stock price has increased by -14.49% in the
last 52 weeks. The beta is 1.47, so 89bio's
price volatility has been higher than the market average.
| Beta | 1.47 |
| 52-Week Price Change | -14.49% |
| 50-Day Moving Average | 7.5 |
| 200-Day Moving Average | 8.24 |
| Relative Strength Index (RSI) | 54.57 |
| Average Volume (20 Days) | 1,884,560 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -384.66M |
| Net Income | -367.08M |
| EBITDA | -384.66M |
| EBIT | -371.68M |
| Earnings Per Share (EPS) | -3.51 |
Full Income StatementBalance Sheet
The company has 126.06M in cash and 37.55M in
debt, giving a net cash position of 88.51M.
| Cash & Cash Equivalents | 126.06M |
| Total Debt | 37.55M |
| Net Cash | 88.51M |
| Retained Earnings | -824.51M |
| Total Assets | 685.03M |
| Working Capital | 645.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -367.82M
and capital expenditures -15K, giving a free cash flow of -367.84M.
| Operating Cash Flow | -367.82M |
| Capital Expenditures | -15K |
| Free Cash Flow | -367.84M |
| FCF Per Share | -3.51 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
